Table 2.
Specific antibiofilm activity (Δbaseline normalized CI × mM-1 × min-1) of the different proteins against 8 h-old biofilms formed by four S. aureus strains (15981, ISP479r, IPLA1, and Sa9).
| Protein (μM) |
S. aureus strains |
|||
|---|---|---|---|---|
| 15981 | ISP479r | IPLA1 | Sa9 | |
| LysH5 (7 μM) | 0.79 ± 0.03a,A | 0.47 ± 0.04b,A | 0.35 ± 0.02c,A | 0.41 ± 0.02b,A |
| CHAP-SH3b (7 μM) | 0.38 ± 0.03a,B | 0.21 ± 0.03b,B | 0.25 ± 0.02c,B | 0.45 ± 0.01d,B |
| HydH5/SH3b (7 μM) | 0.09 ± 0.04a,C | 0.28 ± 0.01b,B | 0.36 ± 0.01c,A | 0.18 ± 0.01d,C |
| Dpo7 (7 μM) | 0.11 ± 0.01a,C | 0.08 ± 0.01b,C | 0.15 ± 0.01c,C | 0.10 ± 0.01d,D |
Values represent mean ± standard deviation of three biological replicates. Values having distinct lower case letter in the same row indicate that the protein treatments are statistically different (p < 0.05) among the strains, while values with distinct capital letter in the same column indicate statistical differences (p < 0.05) between protein treatments within each strain, according to the ANOVA and SLK post hoc comparison test.